Medicaid expansion in Kentucky led to an increase of screening mammograms, screening coverage, and breast-conserving surgery for women aged 20 to 64 with breast cancer, according to a study published in the Journal of the American College of Surgeons. However, the study also showed that time from diagnosis to operation increased post expansion and time from operation to chemotherapy remained unchanged.
Medicaid expansion in Kentucky led to earlier diagnosis and improved quality of care for women aged 20 to 64 with breast cancer, according to a study published in the Journal of the American College of Surgeons. However, the study also showed less robust improvements in efficiency and timing of post-surgical therapy.
Thirty-two states and the District of Columbia have expanded Medicaid coverage since the passage of the Affordable Care Act (ACA) in 2010. “What we learned is that the expansion of some form of third-party coverage for healthcare leads to people doing more things that are intrinsically good for their health,” said senior study author Hiram C. Polk, MD, FACS, division of surgical oncology, University of Louisville, in a press release from the American College of Surgeons.
The authors of the study used the Kentucky Cancer Registry for all women aged 20 to 64 who were diagnosed with breast cancer between 2011 and 2016. Demographics, tumor, and treatment characteristics were assessed for each year during the time frame. The authors then compared 2011-2013 (pre-expansion) to 2014-2016 (post expansion) to determine the association between Medicaid expansion and these factors, as well as quality metrics.
Pre-expansion, 635,547 screening mammograms were performed in Kentucky, compared to 680,418 post expansion; there were 208,600 screening mammograms performed in 2011 alone, compared to 234,315 in 2016. In addition to the amount of screening mammograms performed, the number of screening mammograms covered by Medicaid increased from 5.6% pre-expansion to 14.7% post expansion. The number of uninsured women who had screening mammograms declined almost 10-fold, from .53% to .05%.
The rates of breast-conserving surgery also increased significantly after expansion, from 44% to 48.8%, whereas rates of other resections, such as mastectomy, declined from 50.5% to 44.5%.
While breast cancer incidence and treatment rates did not vary substantially from year to year, the changes in the rates of early-stage versus late-stage disease did; early stage breast cancers accounted for 64.5% of diagnoses pre-expansion versus 66.7% post expansion, and diagnosis of late-stage cancer decreased from 15% pre-expansion to 12.9% post expansion.
However, results also showed that while the time from diagnosis to operation increased post expansion, from 28.6 days to 36 days, the time from operation to chemotherapy remained unchanged, and time from operation to radiation decreased from 96.4 days to 91.5 days.
“The expansion of Kentucky Medicaid in 2014 has been associated with earlier diagnosis and somewhat improved quality of breast cancer care, despite a stable disease incidence,” concluded the authors. “Additional improvements in treatment expediency will require improvements in patient outreach and healthcare infrastructure.”
Reference
Ajkay N, Bhutani N, Huang A, et al. Early impact of Medicaid expansionand quality of breast cancer care in Kentucky [published online February 12, 2018]. J Am Coll Surg. doi: 10.1016/j.jamcollsurg.2017.12.041.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More